Peptide record

TPDB11779

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
38 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11779
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 iACP-DRLF AFP-GFuse Antifungipept CAFPdb
standard
No
A 38-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLLSGILGAGKHIVCGLSGPCQSLNRKSSDVEYHLAKC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C168H280N50O51S3
MFTW
GL
3912.56
8.55
6
2
13
+2
0.66
0.142
102.63
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1615
0.41
11
Residue Composition
number
2
A
1
R
1
N
1
D
3
C
1
E
1
Q
6
G
2
H
2
I
6
L
3
K
0
M
0
F
1
P
5
S
0
T
0
W
1
Y
2
V
Amino Acid Distribution
A: 2 R: 1 N: 1 D: 1 C: 3 E: 1 Q: 1 G: 6 H: 2 I: 2 L: 6 K: 3 M: 0 F: 0 P: 1 S: 5 T: 0 W: 0 Y: 1 V: 2
Chemical Descriptors
38 reviewed residue count
C168H280N50O51S3 sequence-only estimate (linear, free termini)
3912.56 sequence-only estimate (linear, free termini)
8.55 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
0.66 sequence-only estimate (linear, free termini)
0.142 sequence-only estimate (linear, free termini)
Evidence Records 15 records
Evidence 1 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against E. coli (MIC 6.3 ug/ml), S. aureus (MIC 3.1 ug/ml), B. subtilis (MIC 12.5 ug/ml), and C. albicans (MIC 3.1 ug/ml)
Evidence 2 Activity

Activity

MIC
Antibacterial
3.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

active against E. coli (MIC 6.3 ug/ml), S. aureus (MIC 3.1 ug/ml), B. subtilis (MIC 12.5 ug/ml), and C. albicans (MIC 3.1 ug/ml). Aslo histamine release.
Evidence 3 Activity

Activity

MIC
Antibacterial
12.5 µg/mL

Target

B. subtilis

Source & Reference

dbAMP DRAMP

Other

active against E. coli (MIC 6.3 ug/ml), S. aureus (MIC 3.1 ug/ml), B. subtilis (MIC 12.5 ug/ml), and C. albicans (MIC 3.1 ug/ml). Aslo histamine release.
Evidence 4 Activity

Activity

MIC
Antibacterial
3.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

nst E. coli (MIC 6.3 ug/ml), S. aureus (MIC 3.1 ug/ml), B. subtilis (MIC 12.5 ug/ml), and C. albicans (MIC 3.1 ug/ml). Aslo histamine release.
Evidence 5 Activity

Activity

MIC
Antifungal
6.3 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
active against E. coli (MIC 6.3 ug/ml), S. aureus (MIC 3.1 ug/ml), B. subtilis (MIC 12.5 ug/ml), and C. albicans (MIC 3.1 ug/ml)
Evidence 6 Activity

Activity

MIC
Antifungal
3.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active against E. coli (MIC 6.3 ug/ml), S. aureus (MIC 3.1 ug/ml), B. subtilis (MIC 12.5 ug/ml), and C. albicans (MIC 3.1 ug/ml). Aslo histamine release.
Evidence 7 Activity

Activity

MIC
Antifungal
12.5 µg/mL

Target

B. subtilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active against E. coli (MIC 6.3 ug/ml), S. aureus (MIC 3.1 ug/ml), B. subtilis (MIC 12.5 ug/ml), and C. albicans (MIC 3.1 ug/ml). Aslo histamine release.
Evidence 8 Activity

Activity

MIC
Antifungal
3.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

nst E. coli (MIC 6.3 ug/ml), S. aureus (MIC 3.1 ug/ml), B. subtilis (MIC 12.5 ug/ml), and C. albicans (MIC 3.1 ug/ml). Aslo histamine release.
Evidence 9 Activity

Activity

MIC
Antiparasitic
6.3 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
active against E. coli (MIC 6.3 ug/ml), S. aureus (MIC 3.1 ug/ml), B. subtilis (MIC 12.5 ug/ml), and C. albicans (MIC 3.1 ug/ml)
Evidence 10 Activity

Activity

MIC
Antiparasitic
3.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

active against E. coli (MIC 6.3 ug/ml), S. aureus (MIC 3.1 ug/ml), B. subtilis (MIC 12.5 ug/ml), and C. albicans (MIC 3.1 ug/ml). Aslo histamine release.
Evidence 11 Activity

Activity

MIC
Antiparasitic
12.5 µg/mL

Target

B. subtilis

Source & Reference

DRAMP

Other

active against E. coli (MIC 6.3 ug/ml), S. aureus (MIC 3.1 ug/ml), B. subtilis (MIC 12.5 ug/ml), and C. albicans (MIC 3.1 ug/ml). Aslo histamine release.
Evidence 12 Activity

Activity

MIC
Antiparasitic
3.1 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

nst E. coli (MIC 6.3 ug/ml), S. aureus (MIC 3.1 ug/ml), B. subtilis (MIC 12.5 ug/ml), and C. albicans (MIC 3.1 ug/ml). Aslo histamine release.
Evidence 13 Activity

Activity

0% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 50 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Anti-infection peptidomics of amphibian skin. | Mol Cell Proteomics | 2007
Evidence 14 Activity

Activity

(12.5±5.6)% degranulation
Toxicity
50 µg/mL
Cytotoxic
(12.5±5.6)% degranulation | 50 | µg/mL | target cell: Human mast cells

Target

Human mast cells

Source & Reference

NA
DBAASP
Anti-infection peptidomics of amphibian skin. | Mol Cell Proteomics | 2007
Evidence 15 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref:17272268]Non-hemolytic activity against rabbit red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Mol Cell Proteomics. 2007 May 6(5):882-894.